Provided by Tiger Trade Technology Pte. Ltd.

Lexeo Therapeutics

4.84
0.0000
Volume:10K
Turnover:45.59K
Market Cap:397.10M
PE:-4.22
High:4.89
Open:4.76
Low:4.76
Close:4.84
52wk High:10.99
52wk Low:3.99
Shares:82.05M
Float Shares:51.23M
Volume Ratio:0.40
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1457
EPS(LYR):-1.8634
ROE:-46.76%
ROA:-27.59%
PB:1.69
PE(LYR):-2.60

Loading ...

May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 11, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 31, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 30, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2026

Major Issues Report

Form 8-K - Current report
Jan 27, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Nov 26, 2025

Correspondence

Form CORRESP - Correspondence
Nov 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities